Indolamine 2,3-dioxygenase 1 (IDO1) is an intracellular enzyme produced by tumor cells, MDSCs and TAMs that metabolizes tryptophan, negatively impacts effector T cell function and enhances Treg activity, thereby inhibiting the anti-tumor immune response [102]. Here, IDO1 is linked to neoplasm.